Thorac cardiovasc Surg 2019; 67(08): 692-696
DOI: 10.1055/s-0038-1667325
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma

Masatsugu Hamaji
1  Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
,
Ken Yamaguchi
2  Department of Obstetrics and Gynecology, Kyoto University Hospital, Kyoto, Japan
,
Sho Koyasu
3  Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Hospital, Kyoto, Japan
,
Hiroshi Date
1  Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
› Author Affiliations
Further Information

Publication History

28 April 2018

19 June 2018

Publication Date:
07 August 2018 (online)

Abstract

The indication for surgery is controversial in patients with advanced ovarian cancer and fluorodeoxyglucose (FDG)-avid mediastinal lymph nodes. Herein we report our experience in thoracoscopic resection of FDG-avid mediastinal lymph nodes associated with advanced ovarian cancer in six patients. No perioperative or long-term mortality was noted. FDG-avid mediastinal lymph nodes in advanced ovarian carcinoma may merit thoracoscopic resection with histological confirmation for more precise staging.